AniCell Biotech develops and manufactures amnion-derived, acellular extracellular matrix scaffold products for veterinary use.

Since 2015, AniCell has focused on transforming naturally derived amniotic tissue into practical, veterinarian-directed product formats designed to serve as wound coverings, protective barriers, and supplemental scaffolds across a range of veterinary applications.

AniCell maintains oversight throughout the product lifecycle—from donor mare screening and collection through processing, testing, packaging, and distribution—to support product integrity, traceability, and consistent quality. This vertically integrated approach allows AniCell to maintain close control over the material from collection through delivery to the veterinary professional.Our portfolio includes multiple amnion-derived formats designed to provide veterinarians with flexibility based on the tissue environment, anatomical location, application requirements, and individual case plan. AniCell develops amnion-derived scaffold materials designed to provide physical and structural support within veterinarian-directed care.

AniCell is also committed to scientific evaluation and veterinary education. Product-specific research, broader amnion science, practitioner experience, and ongoing quality monitoring contribute to our understanding of how these technologies may be appropriately incorporated into veterinary practice.

Supporting the ACTIVE life of animals.